Meiyi Sun Selected Research

GPA 7

1/2014	Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor.
11/2013	Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meiyi Sun Research Topics

Disease

2	Melanoma (Melanoma, Malignant) 01/2014 - 11/2013
1	Neoplasms (Cancer) 01/2014
1	Human Influenza (Influenza) 08/2013
1	Infections 09/2012

Drug/Important Bio-Agent (IBA)

2	GPA 7IBA 01/2014 - 11/2013
2	AntigensIBA 01/2014 - 11/2013
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2014 - 11/2013
1	Chimeric Antigen ReceptorsIBA 01/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2013
1	Single-Domain AntibodiesIBA 11/2013
1	Immunodominant EpitopesIBA 08/2013
1	ProteomeIBA 08/2013
1	EpitopesIBA 08/2013
1	Peptides (Polypeptides)IBA 09/2012
1	VaccinesIBA 09/2012

Therapy/Procedure

1	Therapeutics 01/2014
1	Immunotherapy 09/2012